Dive into the latest episode of Pharmacy Friends for a discussion of the FDA Commissioner’s National Priority Voucher pilot. While accelerated approvals may improve access to innovative therapies, what could a compressed decision-making window mean for evidence review, affordability assessment and implementation planning?

Prime experts Angela Sutton and Bob Greer explore the important roles clinical confidence and operational readiness will play in making solid coverage decisions. Hear what they’re most focused on, including:

• Managing drug spend
• Assessing coverage strategies
• Determining policy risk

00:00 Introduction

02:10 What's generating all the questions now?

04:35 FDA Hearing

05:50 Pro's and con's of accelerated drug approvals

11:05 Policy uncertainty and impact to payers

11:54 Impact of FDA leadership changes

12:24 Meeting the moment

15:26 Using data to make better decisions that need to be fast

18:39 What we would tell the acting FDA leadership that matters

23:15 Closing

Learn how nurse-led care coordination supports members right after their specialty therapy starts. Learn how the compassionate experts at Prime help members understand their treatment, set expectations and get support when it’s needed.

Tune in to hear how nurse-led coordination is reducing costs and improving care for the better, including:

• Fewer early missteps through clear patient education
• Better member experience through personalized support
• Reduced urgent care and ER visits through early symptom management

Chapters

02:22 - Introduction to care management

05:35 - Care management availability

06:45 - Patient impact of care management

10:17 - Common conditions that care management teams help with

11:52 - Caregiver assistance

14:23 - Better patient outcomes, means stronger health systems

17:33 - The "why" behind care management is about compassion

18:41 - Closing

Recorded live in Nashville at AMCP Annual 2026, our latest Pharmacy Friends shares takeaways on how real-world medical and pharmacy data, pharmacist-led outreach, and benefit integration are shaping payer decision-making.

00:45 - Why real-time evidence matters

09:37 - High-touch pharmacist-to-prescriber outreach helps deliver hard-dollar savings.

23:51 – Rare disease insight and reinforcing the need for individualized management and payer case-management opportunities.

36:02 -- Why site of care in CAR-T and BiTE therapy matter

43:20 – Why mental health parity compliance in government programs matter now

52:55-- Integration signal by highlighting the value of coordinated care.

These insights are foundational to how Prime delivers value to health care payers. Using evidence-driven expertise on how therapies are used, where gaps exist and which patients benefit most from additional support, Prime translates research into smarter clinical strategies and high-touch support for patients.

Dive into the real stories, smart insights, and everyday moments that bring the world of pharmacy and everyday life together—one authentic conversation at a time.